Position | Company | Period |
---|---|---|
Vice President, Controller | Mersana Therapeutics Inc | July 1, 2019 - Dec. 31, 2019 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-18 | 2023-01-17 |
Mersana Therapeutics Inc
(MRSN)
|
S Sale |
3,575
-20.8%
5.7420,521 USD |
3,575 -20.8% | 5.74 | 20,521 USD | |
2022-01-19 | 2022-01-18 |
Mersana Therapeutics Inc
(MRSN)
|
S Sale |
1,982
-37.0%
5.9211,733 USD |
1,982 -37.0% | 5.92 | 11,733 USD | |
2021-01-20 | 2021-01-19 |
Mersana Therapeutics Inc
(MRSN)
|
PS Planned sale |
545
-100.0%
21.2811,598 USD |
545 -100.0% | 21.28 | 11,598 USD | |
2021-01-06 | 2021-01-04 |
Mersana Therapeutics Inc
(MRSN)
|
PS Planned sale |
247
-100.0%
26.766,610 USD |
247 -100.0% | 26.76 | 6,610 USD | |
2020-07-06 | 2020-07-02 |
Mersana Therapeutics Inc
(MRSN)
|
PS Planned sale |
3,383
-100.0%
22.4976,084 USD |
3,383 -100.0% | 22.49 | 76,084 USD | |
2020-07-06 | 2020-06-30 |
Mersana Therapeutics Inc
(MRSN)
|
B Purchase |
3,383
+inf%
4.8716,475 USD |
3,383 +inf% | 4.87 | 16,475 USD |